1 option
Omalizumab treatment for adults and children with allergic asthma : a review of the clinical effectiveness, cost-effectiveness, and guidelines / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author.
- Series:
- Rapid response report (Canadian Agency for Drugs and Technologies in Health)
- Language:
- English
- Subjects (All):
- Asthma--Chemotherapy--Canada.
- Asthma.
- Asthma--Chemotherapy.
- Monoclonal antibodies--Therapeutic use.
- Monoclonal antibodies.
- Asthma--drug therapy.
- Antibodies, Monoclonal--therapeutic use.
- Medical Subjects:
- Asthma--drug therapy.
- Antibodies, Monoclonal--therapeutic use.
- Physical Description:
- 1 online resource (24 pages) : illustrations.
- Place of Publication:
- [Ottawa, Ontario] : Canadian Agency for Drugs and Technologies in Health, 2015.
- Notes:
- Description based on: online resource; title from PDF information screen (NCBI, viewed October 24, 2022).
- "9 March 2015".
- Includes bibliographical references (pages 10-11).
- OCLC:
- 909061113
- Publisher Number:
- 245937 CaOOCEL (Public Documents)
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.